Esphera SynBio

Exomnis Biotech

This company develops engineered bacteria as delivery vehicles for cancer immunotherapies, serving pharmaceutical companies and clinical researchers.

Spot Biosystems

This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.

Synthetic biology-powered mRNA therapeutics

The company develops programmable mRNA therapies using synthetic biology genetic circuits to deliver precise treatments for patients with cancer and other complex diseases.

Syntax Bio

This synthetic biology company develops a CRISPR-based platform to accelerate stem cell differentiation for biopharmaceutical companies developing regenerative medicines and cell therapies.

EverZom

The company develops exosome-based regenerative therapies and a biomanufacturing platform for pharmaceutical laboratories, biotechnology firms, and cosmetics companies.

Exostemtech

This biotechnology firm develops exosome-based therapeutics and production platforms for clinical researchers and healthcare providers treating intractable diseases.

Think Bioscience

This company develops small-molecule therapeutics for pharmaceutical researchers by using synthetic biology and engineered microbes to target difficult-to-drug proteins.

Be Biopharma

This company develops engineered B cell medicines to treat patients with hemophilia B, genetic diseases, and cancer.